Briefs, Europe, Medical, News

CBD suppository to debut

Share this:
  • 7
  •  
  •  
  •  
  •  

Czech-based CB21 Pharma said it has obtained approval for a CBD-infused suppository which will go on the market in pharmacies and online in February. The company said the product helps with healing after childbirth, gynecological procedures and chemotherapy. CB21 said it has plans to develop other products for dentistry and neurology in the coming years. Investments in the development, research and production of CB21 Pharma are financed by Czech billionaire Karel Janeček. The company received a certificate of good manufacturing practice for the production of CBD for pharmaceutical purposes last year. 

Get Hemp Industry Updates

* indicates required

Newsletter Signup

Subscribe to our FREE email newsletter & get the latest hemp industry news directly in your inbox.

* indicates required